We are live on ! Find out more
WG

Winton Group Portfolio holdings

AUM $3.09B
1-Year Est. Return 40.4%
This Fund
S&P 500
This Quarter Est. Return
+2.26%
1 Year Est. Return
+40.4%
3 Year Est. Return
+127.75%
5 Year Est. Return
+204.31%
10 Year Est. Return
+963.71%
AUM
$8.46B
AUM Growth
+$3.31B
Cap. Flow
+$3.24B
Cap. Flow %
38.31%
Top 10 Hldgs %
8.08%
Holding
1,759
New
647
Increased
671
Reduced
187
Closed
252
Avg Time Held
2.9 quarters
Top 10 Avg Time Held
0.8 quarters
Top 20 Avg Time Held
1.1 quarters

Top Buys

Rank Stock Value
1
IBM icon
IBM
IBM
+$59M
2
ACN icon
Accenture
ACN
+$51.7M
3
HPE icon
Hewlett Packard
HPE
+$48.7M
4
UAL icon
United Airlines
UAL
+$43.5M
5
GD icon
General Dynamics
GD
+$38.5M

Top Sells

Rank Stock Value
1
KO icon
Coca-Cola
KO
+$37.5M
2
PEP icon
PepsiCo
PEP
+$36.7M
3
MNST icon
Monster Beverage
MNST
+$35.2M
4
SYF icon
Synchrony
SYF
+$22.9M
5
APC icon
Anadarko Petroleum
APC
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 16.47%
2 Financials 14.61%
3 Real Estate 12.74%
4 Industrials 12.37%
5 Consumer Discretionary 10.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
APVO icon
1476
Aptevo Therapeutics
APVO
$3.24M
– –
0
– –
2019 Q3
0 quarters
ZSAN
1477
DELISTED
Zosano Pharma Corporation
ZSAN
$80K ﹤0.01%
+1,474
New +$132K
2019 Q3
0 quarters
EVC icon
1478
Entravision Communication
EVC
$621M
$76K ﹤0.01%
23,852
+3,386
+17% +$10.7K
2019 Q2
1 quarter
CLDX icon
1479
Celldex Therapeutics
CLDX
$2.35B
$72K ﹤0.01%
+33,661
New +$77.9K
2019 Q3
0 quarters
LXRX icon
1480
Lexicon Pharmaceuticals
LXRX
$748M
$72K ﹤0.01%
+23,838
New +$73.8K
2019 Q3
0 quarters
ONDK
1481
DELISTED
On Deck Capital, Inc.
ONDK
$70K ﹤0.01%
20,797
-32,029
-61% -$114K
2019 Q1
2 quarters
JT
1482
DELISTED
Jianpu Technology Inc. American Depositary Shares, each representing twenty Class A Ordinary Shares
JT
$68K ﹤0.01%
+3,386
New +$91.7K
2019 Q3
0 quarters
KDMN
1483
DELISTED
Kadmon Holdings, Inc.
KDMN
$68K ﹤0.01%
+27,129
New +$67.3K
2019 Q3
0 quarters
VHC icon
1484
VirnetX Holding Corp
VHC
$48.3M
$67K ﹤0.01%
622
+11
+2% +$1.31K
2019 Q2
1 quarter
XXII
1485
22nd Century Group
XXII
$579K
– –
0
– –
2019 Q1
2 quarters
DERM icon
1486
DELISTED
Dermira, Inc.
DERM
$65K ﹤0.01%
+10,207
New +$85.2K
2019 Q3
0 quarters
BBAR icon
1487
BBVA Argentina
BBAR
$2.58B
$64K ﹤0.01%
14,687
+4,189
+40% +$32.6K
2019 Q1
2 quarters
STR icon
1488
DELISTED
Sitio Royalties
STR
$64K ﹤0.01%
+2,803
New +$78K
2019 Q3
0 quarters
LONE
1489
DELISTED
Lonestar Resources US Inc. Class A Common Stock
LONE
$64K ﹤0.01%
+23,579
New +$61.7K
2019 Q3
0 quarters
VBIV icon
1490
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$63K ﹤0.01%
+4,439
New +$93K
2019 Q3
0 quarters
VRAY
1491
DELISTED
ViewRay, Inc.
VRAY
$60K ﹤0.01%
+20,782
New +$123K
2019 Q3
0 quarters
RTW
1492
DELISTED
RTW Retailwinds, Inc.
RTW
$60K ﹤0.01%
+43,571
New +$68.1K
2019 Q3
0 quarters
SENS icon
1493
Senseonics Holdings Inc
SENS
$475M
$58K ﹤0.01%
+2,943
New +$71.3K
2019 Q3
0 quarters
RYAM icon
1494
Rayonier Advanced Materials
RYAM
$475M
$54K ﹤0.01%
12,565
-96,570
-88% -$413K
2019 Q2
1 quarter
GYRE icon
1495
Gyre Therapeutics
GYRE
$746M
$53K ﹤0.01%
+1,430
New +$77.1K
2019 Q3
0 quarters
MRKR icon
1496
Marker Therapeutics
MRKR
$16.2M
$53K ﹤0.01%
1,031
-344
-25% -$20.3K
2019 Q1
2 quarters
APTX
1497
DELISTED
Aptinyx Inc. Common Stock
APTX
$52K ﹤0.01%
+14,998
New +$53.9K
2019 Q3
0 quarters
CHMA
1498
DELISTED
Chiasma, Inc. Common Stock
CHMA
$52K ﹤0.01%
+10,428
New +$59.1K
2019 Q3
0 quarters
PHAS
1499
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$50K ﹤0.01%
+11,990
New +$95.6K
2019 Q3
0 quarters
ADMA icon
1500
ADMA Biologics
ADMA
$2.32B
$48K ﹤0.01%
+10,712
New +$44.8K
2019 Q3
0 quarters
58 59
60
61 62

Similar funds

ZIC
ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return
SP
SurgoCap Partners New York $3.09B AUM 56.85% 1-Year Est. Return
ACM
Advance Capital Management Southfield, Michigan $3.09B AUM 17.08% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
SAM
Smartleaf Asset Management Boston, Massachusetts $3.08B AUM 27.39% 1-Year Est. Return
DMIC
Dixon Mitchell Investment Counsel Vancouver, British Columbia, Canada $3.07B AUM 16.75% 1-Year Est. Return
HC
Henshaw Capital Woburn, Massachusetts $3.07B AUM 40.85% 1-Year Est. Return

Winton Group's Q3 2019 Portfolio in Review

As of Q3 2019, Winton Group held 1,759 positions worth $8.46B, up 64% from $5.14B the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.

Winton Group deployed $3.24B of net new capital in Q3 2019, opening 647 new positions and adding to 671 existing holdings. Its largest new stake was United Airlines: 492,012 shares worth $43.5M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Financials and Real Estate.

On the sell side, the largest reduction was Coca-Cola, an estimated $37.5M trimmed.

  • Winton Group's largest Q3 2019 buy was United Airlines: 492,012 shares worth $43.5M.
  • Winton Group added most to IBM in Q3 2019, an estimated $59M increase.
  • Winton Group's biggest Q3 2019 reduction was Coca-Cola, cutting an estimated $37.5M.
  • Winton Group fully exited Synchrony in Q3 2019, selling an estimated $22.9M.
  • Winton Group's ten largest holdings make up 8.1% of its $8.46B portfolio in Q3 2019.
  • Winton Group opened 647 new positions and closed 252 in Q3 2019.
  • Winton Group's portfolio value rose 64% quarter-over-quarter to $8.46B.

Based on Winton Group's 13F filing for Q3 2019, filed 8 Nov 2019.